Yes there was a sizable fall in ave sale price compared to previous quarter ($34.91 V $25.19). And while this was nominally (more than) offset by falling costs of production ($26.60 to $16.45) I note (page 2) these savings are due to a new IFRS accounting treatments as opposed to real operational improvements, so I suppose we should take that with a grain of salt.
I also note that cash is forecast at $25-35M, at 31 Dec 16, down from $60M at 30 June. I'm not sure to what extent this draw down is due to the inventory build-up reported in this QAR, or some other operational or administrative costs. Thoughts?
It's a dry argument, page-157
Add PDN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.73 |
Change
-0.290(2.89%) |
Mkt cap ! $2.909B | |||
| Open | High | Low | Value | Volume |
| $9.90 | $9.94 | $9.70 | $39.49M | 4.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 18227 | $9.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.73 | 15000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| PDN (ASX) Chart |